Menu

CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: November-18-09
Credit Expiration Date: January-06-11

Faculty

Carla McSpadden, RPh, CGP
Assistant Director, Professional Affairs
American Society of Consultant Pharmacists
Alexandria, VA

Bruce Ferrell, MD
Professor of Medicine
UCLA David Geffen School of Medicine
Los Angeles,CA

Polly Robinson, PharmD, CGP, FASCP
Assistant Professor
Southwestern Oklahoma State University College of Pharmacy
Palliative Care Services
St. John Medical Center
Tulsa, Oklahoma

Credit Hours

Pharmacists: 1.25 Contact Hours (0.125 CEUs)

Medium

Online Presentation

Program Description

NOTE: This activity was presented on November 18, 2009, in conjunction with ASCP's 40th Annual Meeting and Exhibition. Participants who received credit for attending either the live presentation or webcast on that date are not eligible to receive credit for this online activity.

This case-based session will evaluate the efficacy and safety of current opioid analgesics, discuss criteria for compliance with the newly revised CMS surveyor guidance at F-Tag 309 on pain management, and provide practical strategies to appropriately assess, monitor, and manage pain in long term care residents.

Target Audience

This educational activity is designed for consultant pharmacists who care for older adults with pain in long-term care settings.

Learning Objectives

Upon completion of this application-based educational activity, the participant should be able to:

  1. Outline the key points and list the criteria for compliance with the new CMS pain management at F-Tag 309
  2. Describe opportunities for the consultant pharmacist, LTC facility staff, and physicians to work collaboratively to ensure timely and adequate pain management
  3. Summarize practical strategies for recognizing, assessing, and managing pain in the LTC population, particularly for cognitively impaired residents and those experiencing new onset of pain
  4. Evaluate the efficacy and safety of current opioid analgesics to minimize adverse events and optimize pain relief

Disclosures

In accordance with the standards set forth by the Accreditation Council for Pharmacy Education, it is the policy of the American Society of Consultant Pharmacists to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any relevant financial relationship or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with a relevant financial relationship or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speakeršs interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.

Carla McSpadden has no relevant financial relationships to disclose.
Bruce Ferrell has no relevant financial relationships to disclose.
Polly Robinson has no relevant financial relationships to disclose.

This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Credit Statements

The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity, ACPE Universal Activity #203-999-09-073-H01-P, has been assigned 1.25 Contact Hours (0.125 CEUs).

Participants must view the activity in its entirety, successfully complete the post-test, and submit an evaluation to receive continuing pharmacy education credit. Credit will be awarded for a score of 70% or better, and a statement may be printed immediately after passing the post-test.

Partial credit cannot be awarded.

There is no fee to participate in this activity.

Commercial Support Statements

This activity is supported through an educational grant from PriCaraŽ, administered by Ortho-McNeil Janssen Scientific Affairs, LLC

Certificate Fee

$0.00

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS